Skip to Content
Søg Menu
Vi dækker

ECTRIMS | European Committee for Treatment and Research in Multiple Sclerosis

ECTRIMS 2025

ECTRIMS 2024

Sahla El Mahdaoui

The effects of anti-CD20 therapy on TFH cells in relapsing-remitting MS

/ Sahla El Mahdaoui
ECTRIMS24MS Play the Video

ECTRIMS 2024: New Data Has the Potential to Paving the Way for More Personalised and Effective Treatment Plans

/ Jan Andreasen
ECTRIMS24MS

Top 4 mest sete MEDtalks fra ECTRIMS 2024

DMTs During Pregnancy in Women with MS Do Not Affect Relapse Rates in Postpartum Periods

/ Neurologi / Lene Von Kappelgaard

Poor Sleep Has a Deleterious Impact on Health-Related Quality of Life in People with MS

/ Neurologi / Martin Langeskov Christensen

New Biomarker and Comorbidity Insights in NMOSD and MOGAD

/ Neurologi / Nasrin Asgari

Nationwide Patient-Reported Outcome Portal for MS is Feasible and Provides Clinical Value

/ Neurologi / Rolf Pringler Holm

Lina Moschoula Passali

MS: This increase in Blood-Brain Barrier Permeability Appears to be Connected to the Spread of Lesions Across the Brain

/ Lina Moschoula Passali
ECTRIMS24MS Play the Video

Oceans of Hope Project Gives Patients with MS Higher Quality of Life

/ Mikkel Anthonisen
ECTRIMS24MS Play the Video
Ulrik Dalgas

Exercise is Essential for Maximizing Cognitive and Physical Functions for Individuals with MS

/ Ulrik Dalgas
ECTRIMS24MS Play the Video
Lars Hvid

Tværfaglig rehabilitering giver positive langtidseffekter mod fatigue hos personer med MS

/ Lars Hvid
ECTRIMS24MS Play the Video
Marie Lynning

Low Health Literacy is Associated with Lower Levels of Education, Progressive Disease Types and Higher Disease Severity in MS

/ Marie Lynning
ECTRIMS24MS Play the Video
Melinda Magyari

Patients with Secondary Progressive MS Have a Higher Mortality than Those with Primary Progressive MS

/ Melinda Magyari
ECTRIMS24MS Play the Video

Earlier Access to Effective Treatments for Children with MS Reduces the Burden of Long-Term Disability

/ Jan Andreasen
ECTRIMS24MS

ECTRIMS 2024: The World’s Largest MS Congress in Copenhagen 

/ BestPractice Nordic
ECTRIMS24MS

Ublituximab, direkte indplaceret i behandlingsvejledning – bakkes op af nye data ved ECTRIMS24

/ Jan Andreasen
ECTRIMS24MS
Back to top